Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      • Novartis in Ireland 
      • Country Leadership Team 
      • Contact 
      Novartis office
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Education and Awareness 
      • Patient Resources 
      • Adverse Event Reporting 
      • Novartis Societal Impact 
      Happy family outdoors
      Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      • Novartis Ireland travel and Expenses Guidance 
      Healthcare professional talking with patient.
      Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Environmental Sustainability 
      As a global company, Novartis has a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.
      ESG
    • News 
      • News Archive 
      • Stories 
      • Contacts 
      Working on a Tablet
      News
    • Careers 
      • Career Search 
      • Working in Novartis Ireland 
      • Learning and Development 
      • Early Talent 
      • How We Work 
      • Well-being 
      • Diversity & Inclusion 
      • Awards and Recognition 
      Careers
      Careers
    • Investors
      • Financial Data 
    • Coronavirus 
      covid 10 grey image_0_0
      Coronavirus
    Home

Stories

Story Navigation
  • All Topics
  • Education & Awareness
  • Corporate
  • People and Culture
icon
  • Heart_Failure_Image_1
    Education Awareness
    Mar 17, 2022

    Irish Heart Foundation and Michael Lyster Team Up to Draw Attention to the Warning Signs of Heart Failure

    Education Awareness
  • Dublin_Hub_for_European_Patient_Innovation_Summit_Image
    Education Awareness
    Mar 17, 2022

    Dublin Hub for European Patient Innovation Summit

    Patient groups from all over Europe participated in the 2nd annual European Patient Innovation Summit (EPIS 2017), supported by Novartis.

    Education Awareness
  • Vision Assistance App
    Education Awareness
    Mar 17, 2022

    Novartis Launch Vision Assistance Apps to Improve the Lives of the Visually Impaired

    Novartis Launch Vision Assistance Apps to Improve the Lives of the Visually Impaired

    Education Awareness
  • World MS Day 2017 - Quality of Life Research
    Education Awareness
    Mar 17, 2022

    Quality of life for people with Multiple Sclerosis (MS) reported as being one third lower than the general population

    for people with Multiple Sclerosis (MS) reported as being one third lower than the general population

    Education Awareness
  • Fun painting railings for Community Partnership Day
    Education Awareness
    Mar 17, 2022

    Novartis volunteers bring a splash of colour to Presentation Primary School George’s Hill as part of Community Partnership Day

    to Presentation Primary School George’s Hill as part of Community Partnership Day

    Education Awareness
  • Marty Morrissey takes part in heart failure tractor football
    Education Awareness
    Mar 17, 2022

    Marty Morrissey Takes on the Challenge of Heart Failure Tractor Football at the Ploughing Championships

    Marty Morrissey Takes on the Challenge of Heart Failure Tractor Football at the Ploughing Championships

    Education Awareness
  • Launch of employment resource booklets with MS Ireland
    Education Awareness
    Mar 17, 2022

    MS Ireland and Novartis have launched a set of employment resources for people with MS and their employers

    Education Awareness
  • New report reveals that Multiple Sclerosis costs Irish society more than 429 million euros each year
    Education Awareness
    Mar 17, 2022

    New report reveals that Multiple Sclerosis costs Irish society more than 429 million euros each year

    Education Awareness
  • world-heart-day
    Education Awareness
    Mar 17, 2022

    World Heart Day: Politicians, patients and doctors unite to demand action by governments on heart failure (HF)

    Education Awareness
  • asi-report-launch
    Education Awareness
    Mar 17, 2022

    Asthma Society of Ireland Report

    Education Awareness
  • croi-group
    Education Awareness
    Mar 17, 2022

    CROÍ Heart Failure Patient Academy

    Heart Failure Patient Organisations from across the globe come to Ireland to learn from each other and strengthen their role in patient support.

    Education Awareness
  • Burden of Psoraisis group image
    Education Awareness
    Mar 17, 2022

    New Report on Burden of Psoriasis

    Education Awareness

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • › Next page

Novartis Ireland

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Other Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2025 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
Site intended for audiences in Ireland IE417033 March 24